'Lemonade legs': Why do some patients get profound hypomagnesaemia on proton-pump inhibitors?
Proton pump inhibitors (PPIs) are widely used though an association with hypomagnesaemia and hypocalcaemia has only been described since 2006. Patients typically present after years of stable dosing with musculoskeletal, neurological or cardiac arrhythmic symptoms, but it is likely that many cases a...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
Korean Association for the Study of Intestinal Diseases
2015
|